Abstract
Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis.
Yolanda Braun-Moscovici, Doron Markovits, Oren Zinder, Daniel Schapira, Alexander Rozin, Marc Ehrenburg, Lena Dain, Erica Hoffer, A Menahem Nahir and Alexandra Balbir-Gurman
The Journal of Rheumatology March 2006, 33 (3) 497-500;
Yolanda Braun-Moscovici
Doron Markovits
Oren Zinder
Daniel Schapira
Alexander Rozin
Marc Ehrenburg
Lena Dain
Erica Hoffer
A Menahem Nahir
Alexandra Balbir-Gurman
In this issue
Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis.
Yolanda Braun-Moscovici, Doron Markovits, Oren Zinder, Daniel Schapira, Alexander Rozin, Marc Ehrenburg, Lena Dain, Erica Hoffer, A Menahem Nahir, Alexandra Balbir-Gurman
The Journal of Rheumatology Mar 2006, 33 (3) 497-500;
Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis.
Yolanda Braun-Moscovici, Doron Markovits, Oren Zinder, Daniel Schapira, Alexander Rozin, Marc Ehrenburg, Lena Dain, Erica Hoffer, A Menahem Nahir, Alexandra Balbir-Gurman
The Journal of Rheumatology Mar 2006, 33 (3) 497-500;